On Invalid Date, Tenaya Therapeutics (NASDAQ: TNYA) reported Q4 2023 earnings per share (EPS) of -$0.40, up 31.03% year over year. Total Tenaya Therapeutics earnings for the quarter were -$29.94 million. In the same quarter last year, Tenaya Therapeutics's earnings per share (EPS) was -$0.58.
As of Q2 2024, Tenaya Therapeutics's earnings has grown year over year. Tenaya Therapeutics's earnings in the past year totalled -$124.08 million.
What is TNYA's earnings date?
Tenaya Therapeutics's earnings date is Invalid Date. Add TNYA to your watchlist to be reminded of TNYA's next earnings announcement.
What was TNYA's revenue last quarter?
On Invalid Date, Tenaya Therapeutics (NASDAQ: TNYA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Tenaya Therapeutics's revenue was $0.00.
What was TNYA's revenue growth in the past year?
As of Q2 2024, Tenaya Therapeutics's revenue has grown null year over year. Tenaya Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.